<- Go Home
Venus Concept Inc.
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, a portable and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF combined with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, flanks, back, and thighs in individuals with a body mass index BMI of 30 or less; Venus Glow, a Motorized dermabrasion device used to improve skin appearance; and NeoGraft, a hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.
Market Cap
$1.5M
Volume
679.8K
Cash and Equivalents
$4.3M
EBITDA
-$30.9M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$37.9M
Profit Margin
64.36%
52 Week High
$14.50
52 Week Low
$0.75
Dividend
N/A
Price / Book Value
0.56
Price / Earnings
-0.02
Price / Tangible Book Value
4.99
Enterprise Value
$30.3M
Enterprise Value / EBITDA
-1.03
Operating Income
-$34.7M
Return on Equity
794.55%
Return on Assets
-32.43
Cash and Short Term Investments
$4.3M
Debt
$32.7M
Equity
$3.1M
Revenue
$58.9M
Unlevered FCF
-$8.9M
Sector
Health Care Equipment and Supplies
Category
N/A